Correvio Pharma
$0.40759876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$0.4075
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.005 (+1.28%) Today
+$0.0125 (+3.16%) As of 8:00 PM EST after-hours
Why Robinhood?
You can buy or sell CORV and other stocks, options, ETFs, and crypto commission-free!
About CORV
Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. Read More The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients, and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada.
Employees
138
Headquarters
Vancouver, British Columbia
Founded
1986
Market Cap
19.53M
Price-Earnings Ratio
0.00
Dividend Yield
0.00
Average Volume
7.34M
High Today
$0.40
Low Today
$0.3711
Open Price
$0.40
Volume
6.50M
52 Week High
$4.44
52 Week Low
$0.3711
Collections
CORV News
ReutersDec 11
Correvio Pharma to explore sale after FDA panel setback, shares plunge
(Reuters) - Correvio Pharma Corp on Wednesday said it would explore options including putting itself up for sale, a day after a panel of experts advising the U.
CORV Earnings
-$0.37
-$0.27
-$0.17
-$0.07
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
—
Actual
Expected Mar 11, Pre-Market